Anti-endotoxin agents. 2. Pilot high-throughput screening for novel lipopolysaccharide-recognizing motifs in small molecules

Combinatorial Chemistry and High Throughput Screening

Volumn 7, Issue 8, 2004, Pages 733-743

  Wood, Stewart J ^a   Miller, Kelly A ^a   David, Sunil A ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Endotoxin; Fluorescence; High throughput screening; Lipopolysaccharide; Sepsis; Shock

Indexed keywords

ENDOTOXIN; ENDOTOXIN ANTIBODY; LIPID A; LIPOPOLYSACCHARIDE; PHOSPHATE;

ARTICLE; BACTERIAL MEMBRANE; CALORIMETRY; ENTHALPY; FLUORESCENCE; GRAM NEGATIVE BACTERIUM; HIGH THROUGHPUT SCREENING; PHARMACOPHORE; PRIORITY JOURNAL; SEPTIC SHOCK; TOXICITY TESTING;

CALORIMETRY; CELL SURVIVAL; COMPUTER SIMULATION; DRUG EVALUATION, PRECLINICAL; ENDOTOXINS; INDICATORS AND REAGENTS; LIPOPOLYSACCHARIDES; NITRIC OXIDE; STRUCTURE-ACTIVITY RELATIONSHIP;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 9344224012     PISSN: 13862073     EISSN: None     Source Type: Journal    
DOI: 10.2174/1386207043328229     Document Type: Article

References (62)

1. Gelfand, J.A.; Shapiro, L.; New Horizons, 1993, 1, 13.
2. Gasche, Y.; Pittet, D.; Sutter, P. Outcome and prognostic factors in bacteremic sepsis. In Clinical trials for treatment of sepsis, W.J. Sibbald and J.L. Vincent, eds. (Berlin: Springer-Verlag), 1995, pp. 35-51.
3. MMWR, 1990, 39, 31.
4. Martin, G.S.; Mannino, D.M.; Eaton, S.; Moss, M. N. Engl. J. Med., 2003, 348, 1546.
5. Lüderitz, O.; Galanos, C.; Rietschel, E.T. Pharmacol. Ther., 1982, 15, 383.
6. Rietschel, E.T.; Kirikae, T.; Schade, F.U.; Mamat, U.; Schmidt, G.; Loppnow, H.; Ulmer, A.J.; Zähringer, U.; Seydel, U.; Di Padova, F. et al., FASEB J., 1994, 8, 217.
7. Rietschel, E.T.; Brade, L.; Lindner, B.; Zähringer, U. Biochemistry of lipopolysaccharides. In Bacterial endotoxic lipopolysaccharides, vol.1. Molecular biochemistry and cellular biology, D.C. Morrison and J.L. Ryan, eds. (Boca Raton: CRC Press), 1992, pp. 1-41.
8. Hoffman, W.D.; Natanson, C. Anesth. Analg., 1993, 77, 613.
9. Bone, R.C.; Sprung, C.L.; Sibbald, W.J. Crit. Care Med., 1992, 20, 724.
10. Bone, R.C.; Balk, R.A.; Cerra, F.B.; Dellinger, R.P.; Fein, A.M.; Knaus, W.A.; Schein, R.M.; Sibbald, W.J. Chest, 1992, 101, 1644.
11. Bone, R.C. Clin. Chest Med., 1996, 17, 175.
12. Galanos, C.; Lüderitz, O.; Rietschel, E.T.; Westphal, O.; Brade, H.; Brade, L.; Freudenberg, M.A.; Schade, U.F.; Imoto, M.; Yoshimura, S.; Kusumoto, S.; Shiba, T. Eur. J. Biochem., 1985, 148, 1.
13. Ferguson, A.D.; Hofmann, E.; Coulton, J.; Diedrichs, K.; Welte, W. Science, 1998, 282, 2215.
14. Kirikae, T.; Schade, F.U.; Zähringer, U.; Kirikae, F.; Brade, H.; Kusumoto, S.; Kusama, T.; Rietschel, E.T. FEMS Immunol. Med. Microbiol., 1994, 8, 13.
15. Kusumoto, S.; Inage, M.; Chaki, H.; Imoto, M.; Shimamoto, T.; Shiba, T. Chemical synthesis of lipid A for the elucidation of structure-activity relationships. In Bacterial lipopolysaccharides: Structure, synthesis, and biological activities, L. Anderson and F.M. Unger, eds. American Chemical Society) 1983, pp. 237-254.
16. Beutler, B.; Poltorak, A. Drug Metab. Dispos., 2001, 29, 474.
17. Ingalls, R.R.; Heine, H.; Lien, E.; Yoshimura, A.; Golenbock, D. Infect. Dis. Clin. North Am., 1999, 13, 341, vii.
18. Lien, E.; Means, T.K.; Heine, H.; Yoshimura, A.; Kusumoto, S.; Fukase, K.; Fenton, M.J.; Oikawa, M.; Qureshi, N.; Monks, B.; Finberg, R.W.; Ingalls, R.R.; Golenbock, D.T. J. Clin. Invest., 2000, 105, 497.
19. Poltorak, A.; He, X.; Smirnova, I.; Liu, M.Y.; Huffel, C.V.; Du, X.; Birdwell, D.; Alejos, E.; Silva, M.; Galanos, C.; Freudenberg, M.; Ricciardi, C.P.; Layton, B.; Beutler, B. Science, 1998, 282, 2085.
20. Ulevitch, R.J.; Tobias, P.S. Annu. Rev. Immunol., 1995, 13, 437.
21. Ulevitch, R.J. Adv. Immunol., 1993, 53, 267.
22. Marshall, J.C. Nature Rev. Drug. Disc., 2003, 2, 391.
23. Zeni, F.; Freeman, B.; Natanson, C. Crit. Care Med., 1997, 25, 1097.
24. Holst, O.; Ulmer, A.J.; Brade, H.; Rietschel, E.T. On the chemistry and biology of bacterial endotoxic lipopolysaccharides. In Immunotherapy of infections, N. Masihi, ed. (New York, Basel, Hong Kong: Marcel Dekker, Inc.) 1994, pp. 281-308.
25. David, S.A.; Balaram, P.; Mathan, V.I. J. Endotoxin. Res., 1995, 2, 99.
26. David, S.A. The interaction of lipid A and lipopolysaccharide with human serum albumin. In Endotoxins in health and disease, H. Brade, S.M. Opal, S.N. Vogel, and D.C. Morrison, eds. (New York: Marcel Dekker) 1999, pp. 413-422.
27. Bhattacharjya, S.; David, S.A.; Mathan, V.I.; Balaram, P. Biopolymers, 1997, 41, 251.
28. David, S.A.; Bhattacharjya, S.; Mathan, V.I.; Balaram, P. J. Endotoxin. Res., 1994, 1(suppl.), A60.
29. David, S.A.; Balaram, P.; Mathan, V.I. Med. Microbiol. Lett., 1993, 2, 42.
30. David, S.A.; Mathan, V.I.; Balaram, P. Biochim. Biophys. Acta, 1992, 1123, 269.
31. David, S.A.; Awasthi, S.K.; Balaram, P. J. Endotoxin Res., 2000, 6, 249.
32. David, S.A.; Bechtel, B.; Annaiah, C.; Mathan, V.I.; Balaram, P. Biochim. Biophys. Acta, 1994, 1212, 167.
33. David, S.A.; Mathan, V.I.; Balaram, P. J. Endotoxin. Res., 1995, 2, 325.
34. Vaara, M. FEMS Microbiol. Lett., 1983, 18, 117.
35. David, S.A.; Awasthi, S.K.; Wiese, A.; Ulmer, A.J.; Lindner, B.; Brandenburg, K.; Seydel, U.; Rietschel, E.T.; Sonesson, A.; Balaram, P. J. Endotoxin Res., 1996, 3, 369.
36. David, S.A.; Perez, L.; Infante, M.R. Bioorg. Med. Chem. Lett., 2002, 12, 357.
37. David, S.A.; Silverstein, R.; Amura, C.R.; Kielian, T.; Morrison, D.C. Antimicrob. Agents Chemother., 1999, 43, 912.
38. David, S.A. J. Molec. Recognition, 2001, 14, 370.
39. Bush, C.A.; Martin-Pastor, M.; Imberty, A. Annu. Rev. Biophys. Biomol. Struct., 1999, 28, 269.
40. Berman, H.M.; Battistuz, T.; Bhat, T.N.; Bluhm, W.F.; Bourne, P.E.; Burkhardt, K.; Feng, Z.; Gilliland, G.L.; Iype, L.; Jain, S.; Fagan, P.; Marvin, J.; Padilla, D.; Ravichandran, V.; Schneider, B.; Thanki, N.; Weissig, H.; Westbrook, J.D.; Zardecki, C. Acta Crystallogr. D. Biol. Crystallogr., 2002, 58, 899.
41. Roth, R.I.; Tobias, P.S. Infect. Immun., 1993, 61(3), 1033.
42. Hoess, A.; Watson, S.; Siber, G.R.; Liddington, R. EMBO J., 1993, 12, 3351.
43. Kuppermann, N.; Nelson, D.S.; Saladino, R.A.; Thompson, C.M.; Sattler, F.; Novitsky, T.J.; Fleisher, G.R.; Siber, G.R. J. Infect. Dis., 1994, 170, 630.
44. Nelson, D.; Kuppermann, N.; Fleisher, G.R.; Hammer, B.K.; Thompson, C.M.; Garcia, C.T.; Novitsky, T.J.; Parsonnet, J.; Onderdonk, A.; Siber, G.R.; Saladino, R.A. Crit. Care Med., 1995, 23, 92.
45. Garcia, C.; Saladino, R.; Thompson, C.; Hammer, B.; Parsonnet, J.; Wainwright, N.; Novitsky, T.; Fleisher, G.R.; Siber, G. Crit. Care Med., 1994, 22, 1211.
46. Saladino, R.; Garcia, C.; Thompson, C.; Hammer, B.; Personnel, J.; Novitsky, T.; Siber, G.; Fleisher, G. Circ. Shock, 1994, 42, 104.
47. Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney, P.J. Adv. Drug Deliv. Rev., 2001, 46, 3.
48. Rishton, G.M. Drug Discovery Today., 1997, 2, 382.
49. Taylor, R.; Mullier, G.W.; Sexton, G.J. J. Mol. Graph., 1992, 10, 152.
50. Patterson, D.E.; Ferguson, A.M.; Cramer, R.D.; Garr, C.D.; Underiner, T.L.; Peterson, J.R. Design of a Diverse Screening Library. In: High Throughput Screening - The Discovery of Bioactive Substances. In High Throughput Screening - The Discovery of Bioactive Substances, J.P. Devlin, ed. (New York: Marcel-Dekker) 1997, pp. 243-250.
51. Zhang, J.H.; Chung, T.D.; Oldenburg, K.R. J Biomol. Screen., 1999, 4, 67.
52. Green, L.C.; Wagner, D.A.; Glogowski, J.; Skipper, P.L.; Wishnok, J.S.; Tannenbaum, S.R. Anal. Biochem., 1982, 126, 131.
53. Greiss, P. Chem. Ber., 1879, 12, 426.
54. Scudiero, D.A.; Shoemaker, R.H.; Paull, K.D.; Monks, A.; Tierney, S.; Nofziger, T.H.; Currens, M.J.; Seniff, D.; Boyd, M.R. Cancer Res., 1988, 48, 4827.
55. Roehm, N.W.; Rodgers, G.H.; Hatfield, S.M.; Glasebrook, A.L. J Immunol. Methods, 1991, 142, 257.
56. Blagbrough, I.S.; Geall, A.J.; David, S.A. Bioorg. Med. Chem. Lett., 2000, 10, 1959.
57. David, S. A. and Morrison, D. C. Use of synthetic polycationic amphiphilic substances with fatty acid or hydrocarbon substituents as anti-sepsis agents. US Patent 5, 998, 482.
58. Tanaka, S. Iwanaga, S. Methods Enzymol., 1993, 223, 358.
59. David, S. A. Analysis of the desirable structural properties in potential endotoxin antagonists. 1995. Ph.D. Thesis. Christian Medical College Hospital, Vellore, India.
60. Tomalia, D.A.; Naylor, A.M.; Goddard, W.A.I.I. Angew. Chem. Int. Ed. Engl., 1990, 29, 138.
61. Velaquez-Campoy, A.; Todd, M.J.; Freire, E. Biochemistry, 2000, 39, 2207.
62. Todd, M.J.; Luque, I.; Velaquez-Campoy, A.; Freire, E. Biochemistry, 2000, 39, 11876.